What happened
Shares of Luckin Coffee (NASDAQ: LK) plummeted on Friday after the Chinese coffeehouse company disclosed that it will be delisted from the Nasdaq Stock Market.
PCI Media, a producer of animated television commercials and other media, withdrew its plans for an initial public offering on Friday. It originally filed in January 2019 and set terms the following June to raise $18 million by offering 2.5 million units at a price range of $6 to
Investors can't just rely on quarterly earnings results to assess how well a company's doing. Often it's what happens in between those reports that can offer a key glimpse into how well the business performing. And for cannabis companies, a major area of concern these days is ca
In trading on Friday, shares of Xilinx, Inc. (Symbol: XLNX) crossed below their 200 day moving average of $90.64, changing hands as low as $90.41 per share. Xilinx, Inc. shares are currently trading down about 2.7% on the day. The chart below shows the one year performance o
Wall Street's major indexes dropped on Friday as the United States set a new record for a one-day increase in coronavirus cases and bank stocks tumbled after the Federal Reserve decided to cap shareholder payouts.
Upcoming U.S. economic data and deadlines for renewing some fiscal stimulus measures in July could prove key tests for an equities rebound that has wavered in recent weeks.
Canada's Supreme Court on Friday ruled in favor of a driver in a gig economy case that paves the way for a class action suit calling for Uber Technologies Inc to recognize drivers in Canada as company employees.
On Monday, FuelCell Energy (NASDAQ: FCEL) will find itself the new kid in the Russell 3000 Index. The company announced today that it expects to join the index, which tracks U.S. markets' 3,000 largest market cap-weighted stocks, on June 29.
There are dozens of stocks with market caps north of $1 billion that have more than doubled this year. Some of them will struggle to hold on to those gains, but there are some big winners in 2020 that will keep building on earlier gains.
The following are today's upgrades for Validea's Contrarian Investor model based on the published strategy of David Dreman. This contrarian strategy finds the most unpopular mid- and large-cap stocks in the market and looks for improving fundamentals.
The following are today's upgrades for Validea's Growth/Value Investor model based on the published strategy of James P. O'Shaughnessy. This two strategy approach offers a large-cap value model and a growth approach that looks for persistent earnings growth and strong relative
The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.
The major indices recovered a little less than half of yesterday’s sharp selloff on Thursday, thanks to a final-hour rally led by the financials.
Banking regulators loosened restrictions in a move to free up billions of dollars in capital for the big banks. The news came sh
The last few months have been a financial rollercoaster for millions of Americans, to put it mildly. Tens of millions of workers lost their jobs as businesses closed their doors to mitigate the spread of COVID-19, and investors watched their retirement savings take a nosedive.
The coronavirus pandemic has not only shaken people's lives but also economies around the world. Global demand destruction for oil and gas products forced Shell (NYSE: RDS.A) (NYSE: RDS.B) to slash its dividend last quarter; the first time it cut its payout in 75 years. After Sh
Groups of Aviva, Hiscox and QBE policyholders can join Britain's markets watchdog in a High Court case to decide which insurers should pay out to businesses shut by the coronavirus pandemic, a judge said on Friday.
(RTTNews) - Vaxart, Inc. said its oral COVID-19 vaccine has been selected to participate in a non-human primate challenge study, organized and funded by the U.S. Government's Operation Warp Speed. The study is designed to demonstrate the efficacy of the oral COVID-19 vaccine can